XX BIO
LIVE

Serial Number

99207737

Owner

XX BIO, INC.

Attorney

Ava R. Shelby

Filing Date

May 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

XX BIO Trademark

Serial Number: 99207737

XX BIO is a trademark filed by XX BIO, INC. on May 29, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

XX BIO, INC.

1136 Waverley Street
Palo Alto, CA 94301

Entity Type: 03

Trademark Details

Filing Date

May 29, 2025

Registration Date

Not Registered

Published for Opposition

February 10, 2026

Goods & Services

Medical devices for treating age and menopause-related diseases and heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases that only occur or present differently in women; medical diagnostic apparatus for detecting age and menopause-related diseases and diseases that only occur or present differently in women; medical ultrasound apparatus; ultrasound diagnostic apparatus; medical imaging apparatus; medical devices for monitoring heart rate, blood pressure, blood properties, vital signs, respiratory events, and body temperature; medical devices for monitoring psychological conditions; medical products in the nature of devices for treating and diagnosing age and menopause-related diseases and heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases that only occur or present differently in women; medical diagnostic apparatus for detecting diseases in the field of women's health

Pharmaceutical products for the treatment of heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases in the field of women's health; pharmaceutical preparations for the treatment of heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases in the field of women's health; biological preparations for medical and pharmaceutical use, namely, for the treatment of heart, cardiovascular, lymphatic, immune, endocrine, autoimmune, brain, bone, muscle, skin, cerebrovascular, reproductive, metabolic, ovarian, uterine, mental health, and age and menopause-related diseases in the field of women's health; diagnostic biomarker reagents for medical purposes for use in treating diseases in the field of women's health; diagnostic reagents for medical purposes; diagnostic preparations for medical purposes; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; medical diagnostic test strips for blood, urine, and saliva analysis for use in the field of women's health; hormone replacement therapy preparations

Drug discovery services in the field of women's health; scientific research in the nature of conducting clinical trials for others in the field of women's health; biotechnology research in the field of women's health; research and development services in the field of diagnostic preparations

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 14, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 14, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 14, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 14, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2026 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 19, 2025 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 16, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 16, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 29, 2025 MAFR
NEW APPLICATION ENTERED
May 29, 2025 NWAP